Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two Cytochrome P450 3A Inhibitors
-
Published:2023
Issue:1
Volume:260
Page:29-34
-
ISSN:0040-8727
-
Container-title:The Tohoku Journal of Experimental Medicine
-
language:en
-
Short-container-title:Tohoku J. Exp. Med.
Author:
Kumondai Masaki1, Kikuchi Masafumi1, Mizuguchi Atsushi1, Hayashi Nagomi2, Ui Masahiro3, Hirama Takashi3, Okada Yoshinori3, Sato Yu1, Sato Toshihiro1, Maekawa Masamitsu1, Mano Nariyasu1
Affiliation:
1. Department of Pharmaceutical Sciences, Tohoku University Hospital 2. Faculty of Pharmaceutical Sciences, Tohoku University 3. Department of Thoracic Surgery, Tohoku University Hospital
Publisher
Tohoku University Medical Press
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference30 articles.
1. Ando, K., Okada, Y., Akiba, M., Kondo, T., Kawamura, T., Okumura, M., Chen, F., Date, H., Shiraishi, T., Iwasaki, A., Yamasaki, N., Nagayasu, T., Chida, M., Inoue, Y., Hirai, T., et al. (2016) Lung transplantation for lymphangioleiomyomatosis in Japan. PLoS One, 11, e0146749. 2. Barve, A., Kovacs, S.J., Ke, J., Crabbe, R., Grosgurin, P., Menetrey, A., Nicolas-Metral, V., Dabovic, K., Dole, K., Zhang, J., Praestgaard, J., Sunkara, G. & Stein, D. (2015) The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans. Clin. Pharmacol. Drug Dev., 4, 25-32. 3. FDA (United States Food & Drug Administration) (2022) Drug development and drug interactions | Table of substrates, inhibitors and inducers. https://www.fda.gov/drugs/drug-interactions-labeling/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers [Accessed: December 12, 2022] 4. Ferrans, V.J., Yu, Z.X., Nelson, W.K., Valencia, J.C., Tatsuguchi, A., Avila, N.A., Riemenschn, W., Matsui, K., Travis, W.D. & Moss, J. (2000) Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. J. Nippon Med. Sch., 67, 311-329. 5. Gijsen, V.M., van Schaik, R.H., Elens, L., Soldin, O.P., Soldin, S.J., Koren, G. & de Wildt, S.N. (2013) CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients. Pharmacogenomics, 14, 1027-1036.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|